Conference Calls and Earnings Call Transcripts for NSE and BSE Stocks - Q4FY21

Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans - Q4FY21

announcement
Conference/Earnings Calls Alerts
398.55
-3.16%
GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …
BSE India
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company met with Analysts/Investors on Tuesday, 8th March 2022; the details of the same are given below: Sr. no. Name Venue 1 Bellwether Capital Mumbai Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in This is for your information and record.
113.76
-3.50%
302.65
-1.99%
1358.10
-3.76%
HINDALCO INDUSTRIES LTD. - 500440 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of Listing Regulations, please find below the details of the scheduled Investor Meeting which will be attended by the representatives of the Company. Date of Meeting Name of the Fund/Investor 08 March, 2022 ICICI Prudential Asset Management Company Ltd Note: The schedule of the aforesaid meeting may undergo change due to exigencies on the part of Investor/Company. This is to further inform that the copy of latest investor presentation of Q3-FY22 earnings to be made before the Fund House/Investors, can be accessed on the website of the company www.hindalco.com/investor-centre/reports-and-presentations This is for your information and record.
472.45
-2.07%
261.45
-0.63%
Fino Payments Bank Ltd - 543386 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …
BSE India
Pursuant to applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representatives of Fino Payments Bank Limited had the investor/analyst interaction/meeting on March 07, 2022 with BNP Paribas Mutual Fund. Only information available in public domain was given to the investor/analyst. Please take the above information on records and arrange for dissemination. This information is also available on the website of the Company i.e. www.finobank.com
702.00
-5.30%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 7, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
logo
CL Educate Ltd.
07 Mar 2022
93.53
-5.01%
CL Educate Ltd - 540403 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
In continuation to the disclosure dated February 04, 2022 made by us, intimating about the Investors Earnings Call with respect to the Financial Results of the Company for the Quarter and nine months' period ended December 31, 2021, along with a copy of the investor presentation made thereat, we hereby inform that the management of the Company met with the Associates from Flowering Tree Investment Management Pte Ltd (Singapore) today i.e. March 07, 2022, and shared the analyst call (December 2021) presentation.
131.83
-7.46%
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Subject: Intimation of Investor/Analyst meet Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company had a call with Analysts/Investors on Monday, 7th March 2022; the details of the same are given below: Sr. no. Name Venue 1 Faering Capital Zoom Call Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.

Earnings Calls Podcast on